title: While we dither, people continue to die from overdose: Comments on 'Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?'.
authors.affiliation: San Francisco Department of Public Health, Substance Use Research, San Francisco, CA, USA. pcoffin@gmail.com.|University of California, San Francisco, Division of HIV, ID, & Global Health, San Francisco, CA, USA. pcoffin@gmail.com.
authors.forename: Phillip
authors.initials: P
authors.lastname: Coffin
authors.affiliation: Brown University, The Miriam Hospital, Providence, RI, USA.
authors.forename: Josiah
authors.initials: J
authors.lastname: Rich
authors.affiliation: Albany Medical College, Emergency Medicine, Albany, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Dailey
authors.affiliation: Harm Reduction Coalition, New York, NY, USA.
authors.forename: Sharon
authors.initials: S
authors.lastname: Stancliff
authors.affiliation: Northeastern University School of Law and Bouvé College of Health Sciences and University of California, San Diego School of Medicine, CA, USA.
authors.forename: Leo
authors.initials: L
authors.lastname: Beletsky
mesh_terms: D000701:Analgesics, Opioid; D062787:Drug Overdose; D003932:Heroin; D006801:Humans; D009270:Naloxone; D009292:Narcotic Antagonists
chemical_list: D000701:Analgesics, Opioid; D009292:Narcotic Antagonists; D009270:Naloxone; D003932:Heroin
keywords: Emergency medical services; heroin; injection drug use; intranasal naloxone; naloxone; opioid; overdose; prisoner; rescue